Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Publication stageIn Press Journal Pre-Proof
CRediT author statement
Rowena Yip: Conceptualization, Methodology, Formal analysis, Data Curation, Writing-Original Draft, Writing-Review&Editing
David F. Yankelevitz: Conceptualization, Methodology, Formal analysis, Writing-Original Draft, Writing-Review&Editing, Supervision
Claudia I. Henschke: Conceptualization, Methodology, Formal analysis, Writing-Original Draft, Writing-Review&Editing, Supervision
Funding: This study was sponsored in part by the Simons Foundation International, Ltd.
Potential Conflicts of Interest:
Dr. David Yankelevitz is a named inventor on a number of patents and patent applications related to the evaluation of chest diseases including measurements of chest nodules. Dr. Yankelevitz has received financial compensation for the licensing of these patents. In addition, he is a consultant and co-owner of Accumetra, a private company developing tools to improve the quality of CT imaging. He is on the advisory board and owns equity in HeartLung a company that develops software related to CT scans of the chest. He is on the medical advisory board of Median Technology that is developing technology related to analyzing pulmonary nodules and is on the medical advisory board of Carestream, a company that develops radiography equipment and has consulted for Genentech, AstraZeneca and Pfizer.
Dr. Henschke is also an inventor of the patents and pending patents owned by Cornell Research
Foundation (CRF). As of April 2009, she has divested herself of all royalties and other interests arising from these.